These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis. Chang-Hong R, Wada M, Koyama S, Kimura H, Arawaka S, Kawanami T, Kurita K, Kadoya T, Aoki M, Itoyama Y, Kato T. Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257 [Abstract] [Full Text] [Related]
23. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389 [Abstract] [Full Text] [Related]
24. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ. Brain Res; 2009 Dec 11; 1305():168-82. PubMed ID: 19815002 [Abstract] [Full Text] [Related]
25. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Li QX, Mok SS, Laughton KM, McLean CA, Volitakis I, Cherny RA, Cheung NS, White AR, Masters CL. Aging Cell; 2006 Apr 11; 5(2):153-65. PubMed ID: 16626394 [Abstract] [Full Text] [Related]
26. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment. Park JH, Jang HR, Lee IY, Oh HK, Choi EJ, Rhim H, Kang S. Hum Mol Genet; 2017 Sep 15; 26(18):3615-3629. PubMed ID: 28666328 [Abstract] [Full Text] [Related]
27. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells. Oh YK, Shin KS, Yuan J, Kang SJ. J Neurochem; 2008 Feb 15; 104(4):993-1005. PubMed ID: 18233996 [Abstract] [Full Text] [Related]
28. Mutant enzyme provides new insights into the cause of ALS. Marx J. Science; 1996 Jan 26; 271(5248):446-7. PubMed ID: 8560253 [No Abstract] [Full Text] [Related]
29. Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis. Elliott JL. Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug 26; 25(6):1169-85. PubMed ID: 11474839 [Abstract] [Full Text] [Related]
31. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis. Nutini M, Frazzini V, Marini C, Spalloni A, Sensi SL, Longone P. Neuropharmacology; 2011 Jun 26; 60(7-8):1200-8. PubMed ID: 21056589 [Abstract] [Full Text] [Related]
32. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. Watson MR, Lagow RD, Xu K, Zhang B, Bonini NM. J Biol Chem; 2008 Sep 05; 283(36):24972-81. PubMed ID: 18596033 [Abstract] [Full Text] [Related]
33. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Williamson TL, Cleveland DW. Nat Neurosci; 1999 Jan 05; 2(1):50-6. PubMed ID: 10195180 [Abstract] [Full Text] [Related]
34. Lack of apoptosis in mice with ALS. Migheli A, Atzori C, Piva R, Tortarolo M, Girelli M, Schiffer D, Bendotti C. Nat Med; 1999 Sep 05; 5(9):966-7. PubMed ID: 10470053 [No Abstract] [Full Text] [Related]
35. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Cluskey S, Ramsden DB. Mol Pathol; 2001 Dec 05; 54(6):386-92. PubMed ID: 11724913 [Abstract] [Full Text] [Related]
36. Transgenic mouse models of amyotrophic lateral sclerosis. Julien JP, Kriz J. Biochim Biophys Acta; 2006 Dec 05; 1762(11-12):1013-24. PubMed ID: 16675207 [Abstract] [Full Text] [Related]
37. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hadano S, Mitsui S, Pan L, Otomo A, Kubo M, Sato K, Ono S, Onodera W, Abe K, Chen X, Koike M, Uchiyama Y, Aoki M, Warabi E, Yamamoto M, Ishii T, Yanagawa T, Shang HF, Yoshii F. Hum Mol Genet; 2016 Aug 01; 25(15):3321-3340. PubMed ID: 27439389 [Abstract] [Full Text] [Related]
38. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. Kokubo Y, Kuzuhara S, Narita Y, Kikugawa K, Nakano R, Inuzuka T, Tsuji S, Watanabe M, Miyazaki T, Murayama S, Ihara Y. Arch Neurol; 1999 Dec 01; 56(12):1506-8. PubMed ID: 10593307 [Abstract] [Full Text] [Related]
39. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR. Neurobiol Dis; 2005 Dec 01; 20(3):943-52. PubMed ID: 16046140 [Abstract] [Full Text] [Related]
40. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, Shijie J, Ravits J, Horner P, Misawa H, Yamanaka K. Acta Neuropathol Commun; 2016 Feb 18; 4():15. PubMed ID: 26891847 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]